Literature DB >> 8170180

Aggressive medulloblastoma with high-level N-myc amplification.

F H Tomlinson1, R B Jenkins, B W Scheithauer, P A Keelan, S Ritland, J E Parisi, J Cunningham, K D Olsen.   

Abstract

A 27-year-old man was treated for an aggressive cerebellar medulloblastoma that, at operation, exhibited dural invasion. Six months after gross total resection and radiation therapy, a "surgical metastasis" developed in the lower portion of the surgical scar. The tumor grew rapidly down into the right side of his neck. Chemotherapy failed, and he subsequently died. Cytogenetic and molecular genetic studies revealed multiple numeric and structural chromosome abnormalities, including an abnormal chromosome 17p arm, more than 100-fold N-myc amplification, a rearranged c-myc gene, and a 16-base pair deletion involving exon 7 of the p53 gene. We postulate that these genetic features may have contributed to the aggressive behavior of the tumor.

Entities:  

Mesh:

Year:  1994        PMID: 8170180     DOI: 10.1016/s0025-6196(12)62221-6

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  13 in total

1.  Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum.

Authors:  S Marino; M Vooijs; H van Der Gulden; J Jonkers; A Berns
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

Review 2.  Recent advances in embryonal tumours of the central nervous system.

Authors:  Chitra Sarkar; Prabal Deb; Mehar Chand Sharma
Journal:  Childs Nerv Syst       Date:  2005-01-29       Impact factor: 1.475

Review 3.  Molecular diagnostics of CNS embryonal tumors.

Authors:  Stefan M Pfister; Andrey Korshunov; Marcel Kool; Martin Hasselblatt; Charles Eberhart; Michael D Taylor
Journal:  Acta Neuropathol       Date:  2010-09-30       Impact factor: 17.088

Review 4.  Molecular pathogenesis of childhood brain tumors.

Authors:  Torsten Pietsch; Michael D Taylor; James T Rutka
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

5.  Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.

Authors:  Karel Zitterbart; Hana Filkova; Lenka Tomasikova; Eva Necesalova; Iva Zambo; Dagmar Kantorova; Iva Slamova; Vladimira Vranova; Dita Zezulkova; Martina Pesakova; Zdenek Pavelka; Renata Veselska; Petr Kuglik; Jaroslav Sterba
Journal:  J Neurooncol       Date:  2010-07-08       Impact factor: 4.130

Review 6.  Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.

Authors:  Jason T Huse; Eric C Holland
Journal:  Nat Rev Cancer       Date:  2010-05       Impact factor: 60.716

Review 7.  Cellular and molecular pathology of medulloblastoma.

Authors:  J P Provias; L E Becker
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

Review 8.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

9.  c-myc and N-myc promote active stem cell metabolism and cycling as architects of the developing brain.

Authors:  Alice Wey; Paul S Knoepfler
Journal:  Oncotarget       Date:  2010-06

Review 10.  Genetically engineered mouse models of brain cancer and the promise of preclinical testing.

Authors:  Jason T Huse; Eric C Holland
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.